KKR buys controlling stake in Baby Memorial Hospital
Mumbai: Global investment firm, KKR, will acquire a controlling stake in Baby Memorial Hospital, a regional multi-specialty hospital chain in India.
"KKR, and Baby Memorial Hospital have announced the signing of definitive agreements under which funds managed by KKR will acquire a controlling stake in BMH," the release stated.
The investor did not disclose the deal value, but according to industry sources cited by the Financial Express, KKR has acquired a 70% stake in the chain for Rs 2,500 crore.
Founded in 1987 by Dr. K G Alexander, BMH is a multi-specialty hospital chains in Kerala, with a capacity of 1,000 beds across hospitals in Calicut and Kannur, and planned expansions across the region. BMH provides comprehensive services with specialized treatment across 40 medical and surgical departments including cardiology, oncology, neurology, gastroenterology, pediatric and orthopedic care. BMH has invested in top-quality grade medical infrastructure and has multiple quality accreditations across hospitals in its network.
Akshay Tanna, Partner and Head of India Private Equity, KKR, said, “Our investment in BMH reflects our continued thematic focus on healthcare in India. We are pleased to be strategic partners with Dr. K G Alexander and family through this investment, which will aid BMH in expanding its network of hospitals and continuing to invest in medical infrastructure so that its medical services can reach more patients in India. We look forward to drawing from KKR’s network and deep healthcare expertise to take BMH to its next phase of growth and deliver greater impact to its communities.”
Dr. K G Alexander, Founder and Chairman of Baby Memorial Hospital, said, “KKR's investment in BMH is a testament to our unwavering commitment to delivering accessible and quality healthcare services for all. We are pleased to be able to tap into global and local experience in the healthcare sector, which will enable us to accelerate our growth and expand our services across India, and importantly continue to deliver excellence to the patients we serve.”
KKR makes its investment from its Asian Fund IV. The transaction further builds on KKR’s track record in the healthcare sector in India and across Asia Pacific, which includes: Max Healthcare, one of India’s largest hospital networks; Healthium, a Indian medical devices company; Infinx, a tech-enabled healthcare revenue solutions provider; JB Pharma, a branded formulations pharmaceutical company in India; Gland Pharma, a Indian pure-play generic injectable pharmaceutical products company; PHC, provider of medical equipment and clinical healthcare IT systems in Japan; Bushu Pharma, a pure-play contract development and manufacturing company in Japan; and Metro Pacific Hospitals, a private hospital chain in the Philippines.
Additional details of the transaction are not disclosed.
Read also: KKR to buy Healthium Medtech from Apax Funds
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.